Endocrinology, Vol 136, 3800-3806, Copyright © 1995 by Endocrine Society

ARTICLES

Regulation of rat mineralocorticoid receptor expression in neurons by progesterone

M Castren, VK Patchev, OF Almeida, F Holsboer, T Trapp and E Castren
Department of Neuroendocrinology, Max-Planck Institute of Psychiatry, Munich, Germany.

We have studied the effects of progesterone on the transcription of the mineralocorticoid receptor (MR) gene in neurons in vitro and in vivo. Progesterone treatment caused a 2.5-fold increase in activity of the MR promoter in transiently transfected N2A neuroblastoma cells. Similarly, MR promoter activity in GH3 pituitary cells was increased 2-fold after treatment with the specific progesterone receptor agonist R5020, with an even greater induction after priming with 17 beta-estradiol. Progesterone treatment also produced a dose-dependent increase in MR messenger RNA (mRNA) levels in primary hippocampal neuron cultures. In vivo, chronic administration of progesterone to estrogen-primed adrenalectomized/ovariectomized rats significantly increased MR mRNA levels in all hippocampal subfields, as determined by semiquantitative in situ hybridization histochemistry. Whereas chronic estradiol treatment decreased MR mRNA levels in the hippocampus, progesterone administration in the absence of estradiol priming was without any effect. These results indicate that 1) progesterone increases MR mRNA levels in vitro and in vivo; 2) the stimulatory effects of progesterone are at least partially mediated by induction of MR promoter activity; and 3) estrogen priming is essential for the effect of progesterone upon MR mRNA in vivo. Further, they suggest the possibility of heterologous regulation of corticosteroid receptors in the brain, whereby the responsiveness of the limbic-hypothalamo-pituitary-adrenal system to corticosteroids may be modulated.

This article has been cited by other articles:

				E. P. Gomez-Sanchez, J. Samuel, G. Vergara, and N. Ahmad Effect of 3{beta}-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R389 - R393. [Abstract] [Full Text] [PDF]

				B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF]

				C. A. Roca, P. J. Schmidt, and D. R. Rubinow Review : Gonadal Steroids and Affective Illness Neuroscientist, July 1, 1999; 5(4): 227 - 237. [Abstract] [PDF]

				D. M. Vazquez, J. F. Lopez, M. I. Morano, S. P. Kwak, S. J. Watson, and H. Akil {alpha}, {beta}, and {gamma} Mineralocorticoid Receptor Messenger Ribonucleic Acid Splice Variants: Differential Expression and Rapid Regulation in the Developing Hippocampus Endocrinology, July 1, 1998; 139(7): 3165 - 3177. [Abstract] [Full Text] [PDF]

				V. K. Patchev and O. F. X. Almeida Gonadal Steroids Exert Facilitating and ``Buffering'' Effects on Glucocorticoid-Mediated Transcriptional Regulation of Corticotropin-Releasing Hormone and Corticosteroid Receptor Genes in Rat Brain J. Neurosci., November 1, 1996; 16(21): 7077 - 7084. [Abstract] [Full Text] [PDF]